NCT00368706View on ClinicalTrials.gov

A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

solifenacin succinate

Oral

DRUG

tolterodine

oral

Trial Locations (4)

100000

Beijing

200000

Shanghai

310000

Hangzhou

404000

Chongqing

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY